At 35, runner Erica Blackburn discovered that her longtime passion was jeopardized by varicose veins. This article explores how she found relief through a targeted treatment, enabling her to return to the active life she loves.

CervoMed plans to present vital data at the upcoming AD/PD™ 2026 Scientific Conference, reinforcing the rationale for its Phase 3 dementia trial. The findings aim to shed new light on patient population and dosing regimen decisions.

Xenon Pharmaceuticals Inc. has announced positive topline results from the Phase 3 X-TOLE2 study of azetukalner, a novel KV7 potassium channel opener, in treating focal onset seizures. This milestone underscores the company’s commitment to advancing life-changing therapeutics for patients with epilepsy and depression.

A spring workshop series titled “Healthy Living with Diabetes” is open for registration until April 9. Organized by the Aging and Disability Resource Center of Barron and Rusk counties, this program promises to guide participants in more effectively managing diabetes.

One reader’s fears about thyroid cancer and a family history prompt questions about Hashimoto’s disease. A social media site recommends eliminating gluten, dairy, tofu, and tomatoes—raising deeper inquiries about effective dietary changes and the realities of risk.

Diabetes affects millions worldwide, and new efforts highlight how cultural traditions might hold the key to better nutrition. By honoring time-tested recipes, family values, and community support, advocates hope to encourage healthier choices and more sustainable habits.

Traverse City resident Alissia J.R. Lingaur, 46, faced an unexpected medical challenge that highlights the importance of community and health care. Featuring keywords like ALS and neurology, the original article delves into how one adapts mentally and physically to life’s sudden obstacles.

Heartburn is a common annoyance, but it can also be a warning sign of gastroesophageal reflux disease (GERD). Understanding the difference between temporary discomfort and a persistent issue can help you decide when it’s time to seek professional care.

Volunteers in clinical trials for neurodegenerative diseases have been recognized for their remarkable contributions to Alzheimer’s and Parkinson’s research. This year’s award recipients embody the dedication needed to drive progress in finding effective therapies and raising community awareness.

Pennsylvania is facing a surge in Highly Pathogenic Avian Influenza, jeopardizing the state’s $7.1 billion industry. In response, officials are mobilizing personnel, expanding laboratory testing, and allocating millions of dollars in emergency funds. This decisive action underscores the urgent need to safeguard agricultural health and public safety.

A newly approved prostate cancer imaging drug is receiving significant attention as one academic medical center becomes the first in the nation to manufacture it. While detailed information is scarce due to a paywall, this milestone underscores a promising direction for diagnostic advances.

An expectant mother is preparing for her baby’s arrival by insisting that anyone visiting in the first three months be fully vaccinated. Following her doctor’s recommendation, she hopes to protect her newborn by limiting exposure to serious illnesses.

Stanford Medicine researchers have conducted a groundbreaking study indicating that a single vaccine can protect mice from a range of infections. By targeting respiratory viruses, bacteria, and even allergens, this approach offers a potential new pathway for disease prevention.

Teva and Sanofi have released new phase 2b data showing that duvakitug demonstrated clinically meaningful and durable efficacy in patients with ulcerative colitis and Crohn’s disease. The companies plan to discuss these findings at an investor call and webcast on February 17, 2026.

A recent publication warns of potential dangers associated with compounded oral GLP-1 medications, although detailed information remains behind paid access. The article underscores a growing need for healthcare professionals and patients to stay alert to emerging risks.

A strategic partnership has propelled West Chester-based Verrica Pharmaceuticals into the Japanese market, as Torii Pharmaceutical Co. Ltd. launches YCANTH for molluscum contagiosum. The approval, granted in September 2025, marks an important step in offering treatment options to patients suffering from this skin condition.

A 17-year-old Depew High School senior was removed from school for failing to receive a mandatory bacterial meningitis booster shot. A 10-page ruling by Judge Peter Weinmann has upheld the school’s decision, reinforcing the district’s authority to enforce vaccination requirements.

Georgia’s House of Representatives has passed a bipartisan bill permitting pharmacists to prescribe HIV prevention medication. If enacted, this change could make it easier for residents to swiftly access critical healthcare at their local pharmacies.

A decades-old study on brain training continues to show reduced dementia risk for participants. This enduring research, featured in today’s Feeling Fit, underscores the lasting impact of consistent cognitive exercises.

February isn’t just about candy hearts and flowers—it’s also a reminder that heart health deserves our attention. American Heart Month campaigns invite everyone to adopt small but meaningful lifestyle shifts for a healthier future.

A growing body of research is examining how human waste might play a central role in fighting cancer. Though it may sound unconventional, experts say harnessing what is typically discarded could point to a new frontier in medicine.